Search Results | Diabetes Care | American Diabetes Association

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes

Guillaume Marquis-Gravel, Jean-Claude Tardif

Diabetes Care 2021;44(6):1252–1253

DOI: https://doi.org/10.2337/dci20-0076

Published: 18 June 2021

View article titled, Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes

Journal Articles

The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study

Juraj Koska, Raymond Q. Migrino, Keith C. Chan, Kelly Cooper-Cox, Peter D. Reaven

Diabetes Care 2021;44(6):1385–1392

DOI: https://doi.org/10.2337/dc20-2014

Published: 25 January 2021

View article titled, The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study

Journal Articles

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39: 139–148

Tomoya Mita, Naoto Katakami, Hidenori Yoshii, Tomio Onuma, Hideaki Kaneto, Takeshi Osonoi, Toshihiko Shiraiwa, Keisuke Kosugi, Yutaka Umayahara, Tsunehiko Yamamoto, Hiroki Yokoyama, Nobuichi Kuribayashi, Hideaki Jinnouchi, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada, on behalf of the Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial

Diabetes Care 2017;40(6):808

DOI: https://doi.org/10.2337/dc17-er06b

Published: 18 April 2017

View article titled, Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39: 139–148

Journal Articles

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Diabetes Care 2016;39(1):139–148

DOI: https://doi.org/10.2337/dc15-0781

Published: 01 December 2015

View article titled, Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Includes: Supplementary data

Journal Articles

TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis

Hui-ping Gong, MD, Zhi-hao Wang, MD, Hao Jiang, MD, Ning-ning Fang, MD, Ji-sheng Li, PHD, Yuan-yuan Shang, MD, Yun Zhang, MD, Ming Zhong, MD, Wei Zhang, MD

Diabetes Care 2009;32(7):1311–1313

DOI: https://doi.org/10.2337/dc09-0061

Published: 23 April 2009

View article titled, TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis

Includes: Supplementary data

Journal Articles

Preβ1-HDL Concentration Is a Predictor of Carotid Atherosclerosis in Type 2 Diabetic Patients

Satoshi Hirayama, MD, Takashi Miida, MD, Osamu Miyazaki, PHD, Yoshifusa Aizawa, MD

Diabetes Care 2007;30(5):1289–1291

DOI: https://doi.org/10.2337/dc06-1948

Published: 01 May 2007

View article titled, Preβ1-HDL Concentration Is a Predictor of Carotid Atherosclerosis in Type 2 Diabetic Patients

Journal Articles

Combination of Multiple Genetic Risk Factors Is Synergistically Associated With Carotid Atherosclerosis in Japanese Subjects With Type 2 Diabetes

Yoshimitsu Yamasaki, MD, PHD, Naoto Katakami, MD, PHD, Ken’ya Sakamoto, MD, PHD, Hideaki Kaneto, MD, PHD, Munehide Matsuhisa, MD, PHD, Hiroshi Sato, MD, PHD, Masatsugu Hori, MD, PHD, Masakazu Haneda, MD, PHD, Atsunori Kashiwagi, MD, PHD, Yasushi Tanaka, MD, PHD, Ryuzo Kawamori, MD, PHD, Shin-ichi Kuno, PHD

Diabetes Care 2006;29(11):2445–2451

DOI: https://doi.org/10.2337/dc06-0871

Published: 01 November 2006

View article titled, Combination of Multiple Genetic Risk Factors Is Synergistically Associated With Carotid Atherosclerosis in Japanese Subjects With Type 2 Diabetes

Journal Articles

Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men: Role of visceral fat accumulation

Giovanni Targher, MD, Lorenzo Bertolini, MD, Roberto Padovani, MD, Luciano Zenari, MD, Giacomo Zoppini, MD, Giancarlo Falezza, MD

Diabetes Care 2004;27(10):2498–2500

DOI: https://doi.org/10.2337/diacare.27.10.2498

Published: 01 October 2004

View article titled, Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men: <span class="subtitle">Role of visceral fat accumulation</span>

Journal Articles

Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes

Michiaki Fukui, MD, Yoshihiro Kitagawa, MD, Naoto Nakamura, MD, Mayuko Kadono, MD, Shinichi Mogami, MD, Chizuko Hirata, MD, Naoko Ichio, MD, Katsuya Wada, MD, Goji Hasegawa, MD, Toshikazu Yoshikawa, MD

Diabetes Care 2003;26(6):1869–1873

DOI: https://doi.org/10.2337/diacare.26.6.1869

Published: 01 June 2003

View article titled, Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes

Journal Articles

Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: Prospective data from the Bruneck Study

Enzo Bonora, MD, PHD, Stefan Kiechl, MD, Johann Willeit, MD, Friedrich Oberhollenzer, MD, Georg Egger, MD, Riccardo C. Bonadonna, MD, Michele Muggeo, MD

Diabetes Care 2003;26(4):1251–1257

DOI: https://doi.org/10.2337/diacare.26.4.1251

Published: 01 April 2003

View article titled, Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: <span class="subtitle">Prospective data from the Bruneck Study </span>

Journal Articles

Association of NAD(P)H Oxidase p22 phox Gene Variation With Advanced Carotid Atherosclerosis in Japanese Type 2 Diabetes

Rieko Hayaishi-Okano, MD, PHD, Yoshimitsu Yamasaki, MD, PHD, Yoshitaka Kajimoto, MD, PHD, Ken’ya Sakamoto, MD, PHD, Kentaro Ohtoshi, MD, Naoto Katakami, MD, Dan Kawamori, MD, Takeshi Miyatsuka, MD, Masahiro Hatazaki, MD, Yoji Hazama, MD, Masatsugu Hori, MD, PHD

Diabetes Care 2003;26(2):458–463

DOI: https://doi.org/10.2337/diacare.26.2.458

Published: 01 February 2003

View article titled, Association of NAD(P)H Oxidase p22 phox Gene Variation With Advanced Carotid Atherosclerosis in Japanese Type 2 Diabetes

Journal Articles

Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes

Rieko Hayaishi-Okano, MD, Yoshimitsu Yamasaki, MD, PHD, Naoto Katakami, MD, Kentaro Ohtoshi, MD, Shin-Ichi Gorogawa, MD, Akio Kuroda, MD, Munehide Matsuhisa, MD, PHD, Keisuke Kosugi, MD, PHD, Norikiyo Nishikawa, MD, PHD, Yoshitaka Kajimoto, MD, PHD, Masatsugu Hori, MD, PHD

Diabetes Care 2002;25(8):1432–1438

DOI: https://doi.org/10.2337/diacare.25.8.1432

Published: 01 August 2002

View article titled, Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes

Journal Articles

Coronary Artery Disease and Carotid Artery Intima-Media Thickness in Japanese Type 2 Diabetic Patients

Naomi Mitsuhashi, MD, Tomio Onuma, MD, Sayaka Kubo, MD, Naoko Takayanagi, MD, Motoe Honda, MD, Ryuzo Kawamori, MD

Diabetes Care 2002;25(8):1308–1312

DOI: https://doi.org/10.2337/diacare.25.8.1308

Published: 01 August 2002

View article titled, Coronary Artery Disease and Carotid Artery Intima-Media Thickness in Japanese Type 2 Diabetic Patients

Journal Articles

Body Fatness and Fat Distribution as Predictors of Metabolic Abnormalities and Early Carotid Atherosclerosis

Rieko Takami, MD, Noriyuki Takeda, MD, Makoto Hayashi, MD, Akihiko Sasaki, MD, Shinichi Kawachi, MD, Koji Yoshino, MD, Kazuhisa Takami, MD, Kazuya Nakashima, MD, Akifumi Akai, MD, Noriyoshi Yamakita, MD, Keigo Yasuda, MD

Diabetes Care 2001;24(7):1248–1252

DOI: https://doi.org/10.2337/diacare.24.7.1248

Published: 01 July 2001

View article titled, Body Fatness and Fat Distribution as Predictors of Metabolic Abnormalities and Early Carotid Atherosclerosis

Meeting Abstracts

Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.

D C Goff, Jr, R B D'Agostino, Jr, S M Haffner, M F Saad, L E Wagenknecht

Diabetes Care 2000;23(7):1006–1011

DOI: https://doi.org/10.2337/diacare.23.7.1006

Published: 01 July 2000

View article titled, Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.

Meeting Abstracts

Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study.

E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, R Bonadonna, M Muggeo

Diabetes Care 1999;22(8):1339–1346

DOI: https://doi.org/10.2337/diacare.22.8.1339

Published: 01 August 1999

View article titled, Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study.

Journal Articles

Ultrasonographic Manifestations of Carotid Atherosclerosis and Glucose Intolerance in Elderly Eastern Finnish Men

Jaakko Tuomilehto, MD, Qing Qiao, MD, Riitta Salonen, MD, Aulikki Nissinen, MD, Jukka T Salonen, MD

Diabetes Care 1998;21(8):1349–1352

DOI: https://doi.org/10.2337/diacare.21.8.1349

Published: 01 August 1998

View article titled, Ultrasonographic Manifestations of Carotid Atherosclerosis and Glucose Intolerance in Elderly Eastern Finnish Men

Journal Articles

Hyperinsulinemia and Carotid Atherosclerosis in Hypertensive and Control Subjects

Asko O Rantala, MD, Markku Päivänsalo, MD, PHD, Heikki Kauma, MD, Mauno Lilja, MD, PHD, Markku J Savolainen, MD, PHD, Antti Reunanen, MD, PHD, Y Antero Kesäniemi, MD, PHD

Diabetes Care 1998;21(7):1188–1193

DOI: https://doi.org/10.2337/diacare.21.7.1188

Published: 01 July 1998

View article titled, Hyperinsulinemia and Carotid Atherosclerosis in Hypertensive and Control Subjects

Journal Articles

Carotid Atherosclerosis in Adolescents and Young Adults With IDDM: Relation to urinary endothelin, albumin, free cortisol, and other factors

Melpomeni Peppa-Patrikiou, MD, Maria Scordili, MD, Aristidis Antoniou, MD, Maria Giannaki, MD, Maria Dracopoulou, MD, Catherine Dacou-Voutetakis, MD

Diabetes Care 1998;21(6):1004–1007

DOI: https://doi.org/10.2337/diacare.21.6.1004

Published: 01 June 1998

View article titled, Carotid Atherosclerosis in Adolescents and Young Adults With IDDM: Relation to urinary endothelin, albumin, free cortisol, and other factors

Journal Articles

Carotid Atherosclerosis and Serum Lipoprotein(a) Concentrations in Patients With NIDDM

Maki Yamamoto, MD, Genshi Egusa, MD, PHD, Michio Yamakido, MD, PHD

Diabetes Care 1997;20(5):829–831

DOI: https://doi.org/10.2337/diacare.20.5.829

Published: 01 May 1997

View article titled, Carotid Atherosclerosis and Serum Lipoprotein(a) Concentrations in Patients With NIDDM

NARROW

Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes

The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39: 139–148

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis

Preβ1-HDL Concentration Is a Predictor of Carotid Atherosclerosis in Type 2 Diabetic Patients

Combination of Multiple Genetic Risk Factors Is Synergistically Associated With Carotid Atherosclerosis in Japanese Subjects With Type 2 Diabetes

Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men: Role of visceral fat accumulation

Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes

Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: Prospective data from the Bruneck Study

Association of NAD(P)H Oxidase p22 phox Gene Variation With Advanced Carotid Atherosclerosis in Japanese Type 2 Diabetes

Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes

Coronary Artery Disease and Carotid Artery Intima-Media Thickness in Japanese Type 2 Diabetic Patients

Body Fatness and Fat Distribution as Predictors of Metabolic Abnormalities and Early Carotid Atherosclerosis

Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.

Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study.

Ultrasonographic Manifestations of Carotid Atherosclerosis and Glucose Intolerance in Elderly Eastern Finnish Men

Hyperinsulinemia and Carotid Atherosclerosis in Hypertensive and Control Subjects

Carotid Atherosclerosis in Adolescents and Young Adults With IDDM: Relation to urinary endothelin, albumin, free cortisol, and other factors

Carotid Atherosclerosis and Serum Lipoprotein(a) Concentrations in Patients With NIDDM

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only